Andrew Haydon

Adj Assoc Prof


Research output per year

If you made any changes in Pure these will be visible here soon.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.


Research Output

Effect of direct-current magnetic field on the specific absorption rate of metamagnetic CoMnSi: a potential approach to switchable hyperthermia therapy

Ugochukwu, K. C., Sadiq, M. M., Biegel, E. S., Meagher, L., Hill, M. R., Sandeman, K. G., Haydon, A. & Suzuki, K., Jan 2020, In : AIP Advances. 10, 1, 7 p., 015128.

Research output: Contribution to journalArticleResearchpeer-review

Open Access

Metastatic melanoma presenting as intravenous tumourthrombus

Nguyen, J., Clements, W., McLean, C., Haydon, A., Moore, M., Yap, K. SK., Mar, V. & Shackleton, M., 7 Feb 2020, (Accepted/In press) In : Journal of Medical Imaging and Radiation Oncology. 3 p.

Research output: Contribution to journalArticleOtherpeer-review

Patient-reported outcomes in patients with resected, high-risk melanoma with BRAFV600E or BRAFV600K mutations treated with adjuvant dabrafenib plus trametinib (COMBI-AD): a randomised, placebo-controlled, phase 3 trial

Schadendorf, D., Hauschild, A., Santinami, M., Atkinson, V., Mandalà, M., Chiarion-Sileni, V., Larkin, J., Nyakas, M., Dutriaux, C., Haydon, A., Robert, C., Mortier, L., Lesimple, T., Plummer, R., Schachter, J., Dasgupta, K., Manson, S., Koruth, R., Mookerjee, B., Kefford, R. & 3 others, Dummer, R., Kirkwood, J. M. & Long, G. V., 1 May 2019, In : The Lancet Oncology. 20, 5, p. 701-710 10 p.

Research output: Contribution to journalArticleResearchpeer-review

4 Citations (Scopus)

Prediction and monitoring of relapse in stage III melanoma using circulating tumor DNA

Tan, L., Sandhu, S., Lee, R. J., Li, J., Callahan, J., Ftouni, S., Dhomen, N., Middlehurst, P., Wallace, A., Raleigh, J., Hatzimihalis, A., Henderson, M. A., Shackleton, M., Haydon, A., Mar, V., Gyorki, D. E., Oudit, D., Dawson, M. A., Hicks, R. J., Lorigan, P. & 4 others, McArthur, G. A., Marais, R., Wong, S. Q. & Dawson, S. J., 1 May 2019, In : Annals of Oncology. 30, 5, p. 804-814 11 p.

Research output: Contribution to journalArticleResearchpeer-review

8 Citations (Scopus)

Prognostic and predictive value of AJCC-8 staging in the phase III EORTC1325/KEYNOTE-054 trial of pembrolizumab vs placebo in resected high-risk stage III melanoma

Eggermont, A. M. M., Blank, C. U., Mandala, M., Long, G. V., Atkinson, V. G., Dalle, S., Haydon, A., Lichinitser, M., Khattak, A., Carlino, M. S., Sandhu, S., Larkin, J., Puig, S., Ascierto, P. A., Rutkowski, P., Schadendorf, D., Koornstra, R., Hernandez-Aya, L., Di Giacomo, A. M., van den Eertwegh, A. JM. & 12 others, Grob, J. J., Gutzmer, R., Jamal, R., Lorigan, P. C., Lupinacci, R., Krepler, C., Ibrahim, N., Kicinski, M., Marreaud, S., van Akkooi, A. C., Suciu, S. & Robert, C., 1 Jul 2019, In : European Journal of Cancer. 116, p. 148-157 10 p.

Research output: Contribution to journalArticleResearchpeer-review

10 Citations (Scopus)